Showing 121 - 140 results of 1,266 for search '"Lung cancer"', query time: 0.07s Refine Results
  1. 121
  2. 122

    Cost-effectiveness of lazertinib as first-line treatment in patients with -mutated advanced lung cancer by Li-Jung Elizabeth Ku, Jui-Hung Tsai, Li-Jun Chen, Szu-Chun Yang

    Published 2025-01-01
    “…Background: Lazertinib demonstrates efficacy similar to that of osimertinib in the first-line treatment of epidermal growth factor receptor ( EGFR )-mutated advanced lung cancer. However, its cost-effectiveness has not yet been evaluated. …”
    Get full text
    Article
  3. 123
  4. 124
  5. 125
  6. 126

    Comprehensive genomic and transcriptomic profiling of pulmonary nodules in synchronous multiple primary lung cancer by Xingsheng Liu, Kun Qian, Lei Su, Xiaoru Tian, Xin Zhao, Tengteng Wang, Li Han, Zhenzhen Li, Peilong Zhang, Ruotian Wang, Baodong Liu, Yuanbo Li, Xiaogang Tan, Yi Zhang

    Published 2025-02-01
    “…Abstract Background Synchronous multiple primary lung cancer (sMPLC) exhibits distinct histopathological characteristics among pulmonary nodules. …”
    Get full text
    Article
  7. 127
  8. 128

    The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature by Ioanna Tsiouprou, Athanasios Zaharias, Dionisios Spyratos

    Published 2019-01-01
    “…Lung cancer is the second most common cancer in both sexes worldwide. …”
    Get full text
    Article
  9. 129

    Formation of Tumorspheres with Increased Stemness without External Mitogens in a Lung Cancer Model by Juan Sebastian Yakisich, Neelam Azad, Rajkumar Venkatadri, Yogesh Kulkarni, Clayton Wright, Vivek Kaushik, Anand Krishnan V. Iyer

    Published 2016-01-01
    “…Like with most solid tumors, the presence of a subpopulation of cancer stem cells (CSCs) or cancer stem-like cells (CS-LCs) has been associated with chemoresistance and tumor relapse in lung cancer cells. In the absence of serum, CSCs/CS-LCs have the ability to grow as lung tumorspheres (LTSs), and this system is routinely used for isolation and characterization of putative CSCs/CS-LCs. …”
    Get full text
    Article
  10. 130
  11. 131

    Lung Cancer Risk and Genetic Polymorphisms in DNA Repair Pathways: A Meta-Analysis by Chikako Kiyohara, Koichi Takayama, Yoichi Nakanishi

    Published 2010-01-01
    “…Genetic variations in DNA repair genes are thought to modulate DNA repair capacity and are suggested to be related to lung cancer risk. We conducted a meta-analysis of epidemiologic studies on the association between genetic polymorphisms in both base excision repair and nucleotide excision repair pathways, and lung cancer. …”
    Get full text
    Article
  12. 132
  13. 133
  14. 134
  15. 135
  16. 136

    A Case of Lung Cancer with Brain Metastasis following Late-Onset Bipolar Disorder by Shin-Heng Shen, Shwu-Hua Lee

    Published 2021-01-01
    “…To describe a case of lung cancer with brain metastasis in a patient who developed new late-onset bipolar disorder 2 years previously. …”
    Get full text
    Article
  17. 137
  18. 138

    Effects of Ginsenoside Biopolymer Nanoparticles on the Malignant Behavior of Non-Small-Cell Lung Cancer by Weizheng Zhou, Chengliang Cai, Hui Shi, Hai Jin, Xiaowei Wang

    Published 2020-01-01
    “…To explore the effects and mechanism of ginsenoside Rg3 nanoparticles on the malignant behavior of non-small-cell lung cancer. Methods. The nanoparticle carriers were prepared by using an electrostatic system, and the coverage of ginsenoside Rg3 was determined by HPLC after coating the nanoparticle carriers with the ginsenoside Rg3 monomer. …”
    Get full text
    Article
  19. 139

    Significance of the Lesion–Pleura Relationship in Differentiating Peripheral Inflammatory Lesions and Lung Cancers by Tao Y, Zhang WT, Ding C, Fu BJ, Lv FJ, Chu ZG

    Published 2025-01-01
    “…Yang Tao,* Wen-Tao Zhang,* Can Ding, Bin-Jie Fu, Fa-Jin Lv, Zhi-Gang Chu Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fa-Jin Lv; Zhi-Gang Chu, Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, 1# Youyi Road, Yuanjiagang, Yuzhong District, Chongqing, People’s Republic of China, 400016, Tel +86 18723032809, Fax +86 23 68811487, Email cyscitg@hospital.cqmu.edu.cn; chuzg0815@163.comPurpose: To determine the significance of lesion–pleura relationship in differentiating peripheral inflammatory lesions (PILs) and peripheral lung cancers (PLCs).Patients and Methods: From January 2017 to April 2022, a total of 743 patients with 501 PLCs and 292 PILs (≥ 1.5 cm) were retrospectively enrolled. …”
    Get full text
    Article
  20. 140